Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study

Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study

Breast-conserving therapy was once a contraindication in young breast cancer patients (aged ≤40 years). Emerging studies suggest that breast-conserving therapy and mastectomy could achieve similar prognosis in this population. However, the effect of molecular subtype disparity on surgical strategy i...

Full description

Bibliographic Details
Main Authors: Ping Yu MD, Hailin Tang PhD, MD, Yutian Zou MD, Peng Liu MD, Wenwen Tian MD, Kaiming Zhang MD, Xiaoming Xie PhD, MD, Feng Ye MD
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820976667

Internet

https://doi.org/10.1177/1073274820976667

Similar Items